Last reviewed · How we verify
NCT06959303
Effect of Teach-Back Method in Angiography
NA trial testing Teach Back Education in Healthy in 70 participants. Enrolling by invitation.
26 August 2025
Quick facts
| Lead sponsor | Tarsus University |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 70 |
| Start date | 26 June 2025 |
| Primary completion | 26 August 2025 |
| Estimated completion | 26 September 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Teach Back Education
Conditions studied
- Healthy — all drugs for Healthy →
- Angiography — all drugs for Angiography →
Sponsor
Tarsus University
Who can join
18 and older, any sex, with Healthy or Angiography. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effect of discharge training with Teach-Back Method on anxiety, fear of death and knowledge level in patients undergoing coronary angiography. H1: The training given with the Teach-Back Method decreases the anxiety level of coronary angiography patient. H2: The training given with the Teach-Back Method decreases the fear of death level of coronary angiography patient. H3: The training given with the Teach-Back Method increases the knowledge level of coronary angiography patient.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06959303
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Teach Back Education
Trials testing the same drug.
- NCT06841991 — Effect of Teach-Back Method in Colonoscopy · NA · enrolling by invitation
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Tarsus University trials
Trials by the same sponsor.
- NCT07457086 — The Effects of the 4-7-8 Breathing Technique on Sleep Quality, Pain, and Recovery Outcomes in Patients Undergoing Transu · NA · not yet recruiting
- NCT07462390 — Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Levels, Development of Complications, and Hospital Read · NA · withdrawn
- NCT07428421 — The Effect of Supporting the Incision Site With Toys During Mobilization in Children Aged 4-10 Years Undergoing Abdomina · NA · recruiting
- NCT07428408 — The Effect of the Side Kangaroo Position in Newborns Undergoing Noninvasive Mechanical Ventilation · NA · not yet recruiting
- NCT07408921 — Effect of Ice Pack and Warm Gel Pad Use During Drain Removal on Anxiety, Comfort, Physiological Parameters, and Patient · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06959303 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tarsus University
- Last refreshed: 9 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06959303.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing